Opinions

Pages

Displaying 11 - 20 of 2884

Securing Europe’s medicine supply: envisioning a Critical Medicines Act

Em curso (updated on 25/09/2023)
Referência: 
CCMI/212-EESC
Rapporteur: 
Lech PILAWSKI (Employers - GR I/Poland), Lech PILAWSKI (Employers - GR I/Poland) (Employers - GR I / Poland)
Co-rapporteur: 
Thomas STUDENT (Germany)
Reunião plenária: 
583 -
Dec 13, 2023 Dec 14, 2023

The Covid 19-pandemic has drawn attention to the role of the pharmaceutical industry and to production, availability and affordability of medicines and medicinal products on the European market.

Dependency on critical ingredients, such as active pharmaceutical ingredients (APIs), became obvious when China and India limited exports. According to current data, up to 80% of APIs used in Europe and about 40% of finished medicines sold in Europe come from China or India. The European Union's increasing dependence on API supplies has led to a partial loss of capability to manufacture active substances independently, which poses a potential threat to public health in the countries of the European Union.

Corruption in public procurement and its impact on the internal market

Em curso (updated on 22/09/2023)
Referência: 
INT/1023-EESC-2023-01711
Rapporteur: 
José Antonio MORENO DÍAZ (Workers - GR II / Spain)
Co-rapporteur: 
Cristian PÎRVULESCU (Diversity Europe - GR III/Romania)

Corruption and the lack of rule of law undermine the mutual trust that is underpinning the internal market. This opinion should contribute to bringing attention to how challenges to the rule of law affect the internal market and in particular public procurement.

Revision of the late payments Directive

Em curso (updated on 22/09/2023)
Referência: 
INT/1041-EESC-EESC-2023-03705-00-00-AC-TRA
Rapporteur: 
Panagiotis GKOFAS (Diversity Europe - GR III/Greece), Alena MASTANTUONO (Employers - GR I/Czech Republic), Angelo PAGLIARA (Workers - GR II/Italy)

EU rules on late payments have triggered a reduction in payment delays. However, still more than 60% of businesses in the EU are not paid on time and small and medium-sized enterprises are most affected. The initiative will provide relief to SMEs by revising existing EU payment rules based on available and upcoming evidence to promote a definitive shift towards a culture of “prompt payment".

Pharmaceutical package

Em curso (updated on 22/09/2023)
Referência: 
INT/1030-EESC-2023-01968
Referral: 
COM(2023) 190 final COM(2023) 191 final 2023/0125 NLECOM(2023) 191 final 2023/0125 NLECOM(2023) 192 final 2023/0132 CODCOM(2023) 192 final 2023/0132 CODCOM(2023) 193 final 2023/0131 CODCOM(2023) 193 final 2023/0131 COD
Rapporteur: 
Martin SCHAFFENRATH (Diversity Europe - GR III / Austria)
Reunião plenária: 
582 -
Oct 25, 2023 Oct 26, 2023

The Commission is proposing an ambitious revision of the EU pharmaceutical legislation (including a Directive and a Regulation), in order to, inter alia, create a Single Market for medicines, ensure an innovation-friendly framework for research and production and reduce the administrative burden.

Strengthening Multilateralism and core international principles for a rules-based order in a rapidly changing world – The importance of Civil Society contribution to the UN system

Em curso (updated on 15/09/2023)
Referência: 
REX/571-EESC
Rapporteur: 
Christian MOOS (Diversity Europe - GR III / Germany)
Co-rapporteur: 
Tanja BUZEK (Workers - GR II/Germany)
Reunião plenária: 
583 -
Dec 13, 2023 Dec 14, 2023

The EESC is a fervent defender of multilateralism and a rules-based world order. Its External Relations Section deals with many topics relevant to the broad spectrum covered by the United Nations and its specialised agencies, while many EESC opinions refer to core international principles and regularly cite the United Nations.

EU Climate Diplomacy

Em curso (updated on 15/09/2023)
Referência: 
REX/569-EESC
Rapporteur: 
Stefano MALLIA (Employers - GR I / Malta)
Reunião plenária: 
583 -
Dec 13, 2023 Dec 14, 2023

Climate diplomacy frames climate change as an external action policy topic and highlights the need to integrate climate objectives and address climate related risks at the highest diplomatic level and across all policy areas. Through this opinion we build on our previous work in this area and also explore practical aspects of the EU climate diplomacy.

Displaying 11 - 20 of 2884

Pages